Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-quarter-and-full-year-2023-results-and-provides-corporate-update-302095250.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-35-million-secured-credit-agreement-with-innoviva-302078816.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-presentation-at-the-6th-annual-bacteriophage-therapy-summit-302066704.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-third-quarter-2023-results-and-provides-corporate-update-301988168.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-presentation-of-topline-data-from-swarm-pa-clinical-study-at-the-north-american-cystic-fibrosis-conference-301965126.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-first-patient-dosed-in-the-phase-2a-portion-of-the-phase-1b2a-disarm-study-of-ap-sa02-in-adults-with-bacteremia-due-to-staphylococcus-aureus-301937830.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-to-participate-in-the-cantor-global-healthcare-conference-301931868.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-second-quarter-2023-results-and-provides-corporate-update-301899117.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-oral-presentation-detailing-results-from-the-phase-1b2a-swarm-pa-clinical-trial-at-the-6th-world-conference-on-targeting-phage-therapy-301838170.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-first-quarter-2023-results-and-provides-corporate-update-301822662.html